No Data
Press Release: Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan
Aclarion Launches $2.5 Million Share Repurchase Program
Aclarion Announces $2.5 Million Stock Repurchase Plan
Aclarion, Inc. Secures U.S. Patent for AI-Enhanced Machine Learning Platform in Chronic Low Back Pain Diagnosis
Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain
Aclarion Receives Pinnacle Award for AI Innovation
Drosen21 OP : easy +10% today